Gene Mack, CEO, GAIN Therapeutics, shares how growing clinician confidence and strong early experiences helped accelerate ...

Insightec, the Miami-based innovator in focused ultrasound to transform patient care, announced July 8 the U.S. Food and Drug ...

New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford scientists reporting improvement in neuron communication in mice.

Gait changes such as swinging the arms differently and taking smaller, slower steps ...

A new therapeutic that could slow down or halt the progression of Parkinson's disease has completed Phase 1 trials with positive results. Researchers and doctors spoke about the findings.

Ozzy Osbourne lived with Parkinson's disease for years before his death. Here's what you need to know about the ...

On a special episode (first released on May 29, 2025) of The Excerpt podcast: Parkinson’s is a disease that afflicts an estimated 90,000 Americans every year. Dr. Lorenz Studer and Dr. Viviane ...

Parkinson's is a progressive neurodegenerative disease that is currently incurable. It is typically only diagnosed once ...

An early-stage clinical trial in France appeared to help restore some brain function for three Parkinson's patients. View on ...

Another 2024 study found that Parkinson’s disease patients taking lixisenatide, an injectable medication used to treat diabetes, experienced less progression of motor symptoms than people with ...

Parkinson’s disease diagnoses have doubled since the 1990s, affecting 10 million people around the world, including “Back to the Future” icon Michael J. Fox and science communication ...

Dr. Melinda Cail from Primary Health Partners joins us in the KFOR Studios on Thursday afternoon to discuss Parkinson's disease.